Association of Delayed Denosumab Dosing with Increased Risk of Fractures: A Population-Based Retrospective Study

Background Inhibitory effects of denosumab on bone remodeling are reversible and disappear once treatment is discontinued. Herein, we examined whether and to what extent delayed denosumab administration is also associated with fracture risk using nation-wide data. Methods The study cohort included w...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Kyoung Min Kim, Seol A Jang, Nam Ki Hong, Chul Sik Kim, Yumie Rhee, Seok Won Park, Steven R. Cummings, Gi Hyeon Seo
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Korean Endocrine Society 2024-12-01
coleção:	Endocrinology and Metabolism
Assuntos:	denosumab fractures osteoporosis discontinuation
Acesso em linha:	http://www.e-enm.org/upload/pdf/enm-2024-2047.pdf
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!